Mental & behavioral health
Mental & behavioral health
The industry experts in mental and behavioral health
Milliman mental & behavioral health solutions
Mental health parity compliance
Milliman mental & behavioral health insight
What's trending in benefits? Mental health benefits survey 2024
In 2024, employee well-being remains the most important reason employers offer mental health resources, according to our latest Pulse Survey.
Trends in psychotropic and other select central nervous system drug overdose deaths
Appropriate clinical supervision and prescription management may help mitigate the overdose risks associated with psychotropics or select CNS medications.
Household dynamics in the prevalence of mental health conditions and substance use disorders
This paper studies the prevalence of mental health and substance use disorders within commercially insured families in the United States.
Impact of Mental Health Parity and Addiction Equity Act
What has happened to utilization and costs for mental health and substance use disorder benefits as the mental health parity laws and associated rules were slowly rolled out?
Institution for Mental Disease (IMD) as an "in lieu of" service
Beyond the impact of the final rule, IMDs will continue to be a topic of interest to state policy makers as they bolster the continuum of behavioral health and substance use disorder services.
Costs and comorbidities of opioid use disorder
This study assesses the prevalence and costs associated with comorbid chronic medical conditions among individuals with diagnosed opioid use disorder (OUD) and opioid super-users without diagnosed OUD.
Transgender healthcare coverage: Prevalence, recent trends, and considerations for payers
A discussion of trends, including recent federal and state laws affecting health insurance benefits for transgender individuals and health insurance clinical coverage policies related to gender reassignment surgery.
Opioid prescription drug patterns in diagnosed and non-diagnosed opioid use disorder populations
This paper presents a comparison of opioid prescription drug patterns among diagnosed and non-diagnosed opioid use disorder populations.
Opioid use disorder in the U.S.: Diagnosed prevalence by payer, age, sex, and state
Over 25 million American adults report suffering from daily chronic pain. The increasing use of opioids in recent years has taken a human toll, leading to a rising number of overdose deaths and diagnoses of opioid use disorder.
Opioid use disorder: Costs, utilization, and comorbidities
Many patients with opioid use disorder have complex healthcare needs, contributing to their significant healthcare costs.
Financial sustainability of an integrated medical-behavioral primary care practice
The state of Colorado has implemented behavioral healthcare in primary medical care settings under a Centers for Medicare and Medicaid Services State Innovation Model Award.
Nonquantitative treatment limitations in the spotlight
Nonquantitative treatment limitations continue to be a source of difficulty for many health plans in attaining compliance with the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008.
The final rules for the Mental Health Parity and Addiction Equity Act of 2008
Final rules clarify how to comply with provisions of the Mental Health Parity and Addiction Equity Act of 2008.
Critical Point Episode 7: Diagnosing and predicting opioid use disorder
Stoddard Davenport and Joseph Boschert discuss their latest research on opioid use in the United States, including underdiagnoses and how advanced analytics can help predict whether a patient may develop opioid use disorder.
Expansion of ASD treatment to a Medicaid EPSDT benefit
Treatment for autism is now a required Medicaid state plan benefit under the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) program.
Assisting Medicaid beneficiaries to achieve housing stability
This brief scopes out the issue of homelessness and housing security and Medicaid’s role in addressing the issue.